St. Paul, MN – January 13, 2026 – Spineology Inc., the pioneer in conforming patient-specific expandable implant technology, today announced the launch of OptiMesh HA Nano, the company’s latest advancement in personalized spinal care. The launch represents a significant step forward in expandable interbody fusion innovation, combining Spineology’s proprietary OptiMesh® expandable interbody implant platform with Promimic AB’s patented HA Nano Surface technology.
OptiMesh HA Nano technology integrates a well-studied nano-thin hydroxyapatite surface treatment designed to create an ultra-hydrophilic absorption environment that supports cellular interaction at the bone-implant interface. The HA Nano surface is intended to promote rapid cellular response and establish a three-dimensional bioactive surface area, with the goal of accelerating osseointegration and reducing the potential risk of infection. This patented surface technology has been shown to enhance biological performance by encouraging stronger and faster bonding between bone and implant.
“This addition of the HA Nano technology to the OptiMesh portfolio underscores our continued commitment to innovation and patient-specific care,” said Brian Snider, Chief Executive Officer of Spineology. “The OptiMesh platform is uniquely built on our conform and expand implant technology that adapts to individual patient anatomy. Now, Spineology delivers a first-of-its-kind solution that integrates a well-studied surface treatment, optimized to support spinal fusion goals, and promote osseointegration.”
The OptiMesh implant undergoes the same rigorous testing as traditional expandable implant technology, meeting all required ASTM testing standards, and FDA clearance requirements, and is demonstrated to maintain long term structural stability with posterior supplemental fixation. OptiMesh® HA Nano is the first conformable, engineered mesh interbody implant platform to incorporate this nano-scale hydroxyapatite surface technology through a proprietary application process. This milestone reinforces Spineology’s commitment to advancing expandable implant technology through surface innovation designed to support lumbar interbody fusion procedures.
About Spineology
Spineology Inc. are the pioneers of Conform and Expand™ technology, a novel development method used in the design of spinal expandable implants. Spineology’s core portfolio, OptiMesh is the only conforming patient specific spinal implant on the market. OptiMesh is backed with IDE level data which further sets the company apart from traditional fusion procedures. OptiMesh is designed to enable surgeons to support outcomes, and patient recovery while minimizing tissue disruption. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions.
For more information about Spineology, visit Spineology.com, and follow us on LinkedIn, or X.
For Media Inquiries:
Amanda Bloom
Executive Vice President of Marketing
651-256-8533
abloom@spineology.com
About Promimic AB
Promimic is a growth company that develops and markets biomaterials for improved osseointegration to leading companies in the fields of dental and orthopedic implants. HAnano Surface® has been developed from cutting edge research at Chalmers University of Technology in Sweden. The technology is proven to improve osseointegration in over 30 scientific studies and with over 2.3 million implants in clinical use. Promimic has offices in Mölndal, Sweden; Austin, Texas; and Warsaw, Indiana.
Visit www.promimic.com to learn more.